Search Within

Stephen D Nimer

  1. "Gerard Donnelly"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (1)
Groups
  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Hematologic Malignancies, Division of (6)
  4. Lymphoma (6)
  5. Nursing (4)
  6. Radiation Oncology, Department of (3)

More Groups

People
  1. Andrew Zelenetz (6)
  2. Craig Moskowitz (6)
  3. Gerard Donnelly (6)
  4. Tarun Kewalramani (5)
  5. Eric Hedrick (4)
  6. Joachim Yahalom (3)

More People

Years
  1. 2003 (1)
  2. 2002 (1)
  3. 2001 (1)
  4. 2000 (1)
  5. 1999 (2)
Publications
  1. Blood (6)
Publishers
  1. American Society of Hematology (6)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial treatment of mantle cell lymphoma with sequential radioimmunotherapy with Tositumomab/Iodine I131 I-Tositumomab followed by CHOP chemotherapy results in a high complete remission rate
    Meeting Abstract

    Zelenetz, A. D.; Donnelly, G.; Halaas, J.; Sgouros, G.; Humm, J.; Popplewell, L.; Reyes, S.; Maignan, K.; Campbell, C.; Moskowitz, C. H.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • An analysis of accelerated full course chemotherapy followed by upfront high dose therapy (HDT) and autologous stem cell transplantation (ASCT) for patients with International Prognostic Index IV (IPI IV) aggressive NHL
    Meeting Abstract

    Moskowitz, C. H.; Kewalramani, T.; Donnelly, G.; Zelenetz, A. D.; Noy, A.; Rice, D.; Kuznetsov, M.; Straus, D.; Nimer, S. D.; Portlock, C. S.
    Blood (2002)

    Fulltext@MSK | Save
  • Rituximab significantly increases the complete response rate in patients with relapsed or primary refractory DLBCL receiving ICE as second-line therapy (SLT)
    Meeting Abstract

    Kewalramani, T.; Zelenetz, A.; Bertino, J.; Donnelly, G.; Hedrick, E.; Noy, A.; O'connor, O.; Portlock, C.; Straus, D.; Yahalom, J.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: An intention-to-treat analysis
    Journal Article

    Kewalramani, T.; Zelenetz, A. D.; Hedrick, E. E.; Donnelly, G. B.; Hunte, S.; Priovolos, A. C.; Qin, J.; Lyons, N. C.; Yahalom, J.; Nimer, S. D.; more...
    Blood (2000)

    Fulltext@MSK | Save
  • Factors predicting outcome in patients with primary refractory intermediate grade lymphoma (IGL) eligible for high dose chemoradiotherapy (HDT) and autologous stem cell transplant (ASCT)
    Meeting Abstract

    Kewalramani, T.; Hedrick, E. E.; Donnelly, G. B.; Satagopan, J. M.; Hunte, S.; Priovolos, A.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (1999)

    Fulltext@MSK | Save
  • Persistent gallium avidity after second-line chemotherapy in Hodgkin's disease (HD) and intermediate-grade non-hodgkin's lymphoma (IGL) does not predict outcome following autologous stem cell transplantation (ASCT)
    Meeting Abstract

    Donnelly, G. B.; Hedrick, E. E.; Kewalramani, T.; Satagopan, J. M.; Walits, J.; Yahalom, J.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (1999)

    Fulltext@MSK | Save